OMCL Strangle Strategy

OMCL (Omnicell, Inc.), in the Technology sector, (Information Technology Services industry), listed on NASDAQ.

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

OMCL (Omnicell, Inc.) trades in the Technology sector, specifically Information Technology Services, with a market capitalization of approximately $1.83B, a trailing P/E of 89.01, a beta of 0.96 versus the broader market, a 52-week range of 26.85-55, average daily share volume of 623K, a public-listing history dating back to 2001, approximately 4K full-time employees. These structural characteristics shape how OMCL stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.96 places OMCL roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 89.01 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple.

What is a strangle on OMCL?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current OMCL snapshot

As of June 29, 2026, spot at $40.55, ATM IV 54.60%, IV rank 7.57%, expected move 15.65%. The strangle on OMCL below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.

Why this strangle structure on OMCL specifically: OMCL IV at 54.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a OMCL strangle, with a market-implied 1-standard-deviation move of approximately 15.65% (roughly $6.35 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated OMCL expiries trade a higher absolute premium for lower per-day decay. Position sizing on OMCL should anchor to the underlying notional of $40.55 per share and to the trader's directional view on OMCL stock.

OMCL strangle setup

The OMCL strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With OMCL near $40.55, the first option leg uses a $42.58 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed OMCL chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 OMCL shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$42.58	N/A
Buy 1	Put	$38.52	N/A

OMCL strangle risk and reward

Net Premium / Debit: N/A
Max Profit (per contract): Unbounded
Max Loss (per contract): Unbounded
Breakeven(s): None on modeled curve
Risk / Reward Ratio: N/A

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

OMCL strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on OMCL. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use strangle on OMCL

Strangles on OMCL are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the OMCL chain.

OMCL thesis for this strangle

The market-implied 1-standard-deviation range for OMCL extends from approximately $34.20 on the downside to $46.90 on the upside. A OMCL long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current OMCL IV rank near 7.57% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on OMCL at 54.60%. As a Technology name, OMCL options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to OMCL-specific events.

OMCL strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. OMCL positions also carry Technology sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move OMCL alongside the broader basket even when OMCL-specific fundamentals are unchanged. Always rebuild the position from current OMCL chain quotes before placing a trade.

Frequently asked questions

What is a strangle on OMCL?: A strangle on OMCL is the strangle strategy applied to OMCL (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With OMCL stock trading near $40.55, the strikes shown on this page are snapped to the nearest listed OMCL chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are OMCL strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the OMCL strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 54.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a OMCL strangle?: The breakeven for the OMCL strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current OMCL market-implied 1-standard-deviation expected move is approximately 15.65%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on OMCL?: Strangles on OMCL are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the OMCL chain.
How does current OMCL implied volatility affect this strangle?: OMCL ATM IV is at 54.60% with IV rank near 7.57%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.